Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming Strategies

NCT: NCT02986074 · COMPLETED

NCT IDNCT02986074
StatusCOMPLETED
Start Date2016-11
Completion2019-08-19
SponsorAbbott Medical Devices (INDUSTRY)
First posted
Last updated

Brief Summary

The study will compare therapeutic efficacy of a novel spinal cord stimulation leads implant based on anatomical landmarks with standard surgical implantation technique.

Frequently Asked Questions

What is CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming Strategies?

CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming Strategies is a clinical trial registered under NCT02986074. Current status: COMPLETED.

What is the status of NCT02986074?

The current status of NCT02986074 (CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming Strategies) is: COMPLETED.

When did CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming Strategies start?

CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming Strategies started on 2016-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑